Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It's a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved ...

With its recent $160 million deluge of funding seemingly burning a hole in its pocket, Akili Interactive has set its sights on building out its slate of video game-based treatments for attention ...

The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined ...

Akili Interactive’s video game-like digital medicine has improved attention and inhibitory control in children with ADHD. Success against the primary endpoint in the pivotal trial sets Akili up to ...

In 2020, Akili Interactive got FDA clearance for its first product, a video game intended to improve attention in kids with ADHD. Now, more than a year later, the company is working through the ...